How Primary Care Clinics Can Play a Key Role in Combating the Opioid Crisis

Primary care clinics play a vital role in combating the opioid crisis by expanding access to medication-assisted treatment, reducing stigma, and integrating comprehensive substance use disorder care within primary care settings.
The United States is currently experiencing a severe opioid epidemic, with overdose deaths from synthetic opioids like fentanyl rising dramatically—over 100-fold since 1999. Medications such as buprenorphine, methadone, and naltrexone are proven effective in treating opioid use disorder (OUD), reducing relapse rates, overdoses, and fatalities. However, numerous barriers hinder access to these lifesaving treatments, including insufficient provider training and stigma faced by individuals with OUD, which discourages them from seeking specialist care.
Psychologist Erin Kelly, Ph.D., highlights that small obstacles can significantly impact those in the throes of withdrawal or addiction. In response, a team led by Dr. Kelly established a dedicated substance use disorders clinic within a primary care setting at Jefferson, complemented by a residency program focused on expanding access to medication-assisted treatment (MAT). Their objective was to create low-barrier access to medications by integrating OUD treatment within primary care, positioning these clinics as frontline responders to the crisis.
Initially, primary care providers (PCPs) received training to earn X-Waiver certification—required until 2022—to prescribe certain OUD medications. They also underwent education in harm reduction and trauma-informed care. The most significant uptick in treatment prescriptions was observed after the establishment of the specialized clinic, with patient feedback overwhelmingly positive about the ease of access and the non-stigmatizing approach by their providers.
Dr. Jaffe emphasizes that programs like this can be expanded to better equip PCPs at the front lines of the opioid epidemic. The study associated with this initiative was conducted with the support of students and postdoctoral researchers at Sidney Kimmel Medical College. According to Dr. Jaffe, enhancing primary care providers' capacity to do substance use screening and provide treatment is crucial in addressing the epidemic effectively.
Efforts such as embedding substance use disorder clinics within primary care practices demonstrate promising results in increasing treatment access and reducing stigma. It underscores the importance of empowering primary care providers with the necessary training and resources to combat one of the most pressing public health challenges today.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Regeneron Acquires 23andMe Out of Bankruptcy for $256 Million
Regeneron Pharmaceuticals is set to acquire 23andMe out of bankruptcy for $256 million, gaining access to extensive genetic data that could accelerate biotech research. The deal follows 23andMe’s recent financial struggles and data breach impact.
Breakthrough in Childhood Leukemia Treatment by Targeting Fusion Proteins
Innovative research identifies new therapeutic targets in childhood leukemia, using combination therapy to improve survival rates in NUP98 fusion-driven AML.
Federal Court Blocks Effort to Cut Medicaid Funding for Planned Parenthood
A federal court has temporarily blocked the federal government from cutting Medicaid funding to Planned Parenthood clinics nationwide, ensuring continued access to essential reproductive health services amidst ongoing legal challenges.



